Our findings above suggest the levels of ST6GAL1 are also upregulated in aggressive prostate tumour tissue, however it is unclear whether the levels of blood borne ST6GAL1 are also higher in men with more aggressive disease. Here, ST6GAL1 is linked to prostate neoplasm.